Shandong Buchang Pharmaceuticals Co Ltd Asset Resilience Ratio
Shandong Buchang Pharmaceuticals Co Ltd asset resilience ratio. Shandong Buchang Pharmaceuticals Co Ltd (603858) has an Asset Resilience Ratio of 3.47% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Shandong Buchang Pharmaceuticals Co Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Shandong Buchang Pharmaceuticals Co Ltd (2016–2024)
Asset resilience ratio of Shandong Buchang Pharmaceuticals Co Ltd from 2016 to 2024. This chart shows how Shandong Buchang Pharmaceuticals Co Ltd's Asset Resilience Ratio has changed over time. Read total liabilities of Shandong Buchang Pharmaceuticals Co Ltd for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Shandong Buchang Pharmaceuticals Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 603858 asset base.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥679.28 Million | 3.47% |
| Total Liquid Assets | CN¥679.28 Million | 3.47% |
Asset Resilience Insights
- Limited Liquidity: Shandong Buchang Pharmaceuticals Co Ltd maintains only 3.47% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Shandong Buchang Pharmaceuticals Co Ltd Industry Peers by Asset Resilience Ratio
Compare Shandong Buchang Pharmaceuticals Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Ajanta Pharma Limited
NSE:AJANTPHARM |
Drug Manufacturers - Specialty & Generic | 14.99% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262 |
Drug Manufacturers - Specialty & Generic | 26.45% |
|
Porton Fine Chemicals Ltd
SHE:300363 |
Drug Manufacturers - Specialty & Generic | 6.85% |
|
Jubilant Pharmova Limited
NSE:JUBLPHARMA |
Drug Manufacturers - Specialty & Generic | 1.26% |
Shandong Buchang Pharmaceuticals Co Ltd Asset Resilience Ratio by Year (2016–2024)
Shandong Buchang Pharmaceuticals Co Ltd asset resilience ratio by year from 2016 to 2024. The table below shows the annual Asset Resilience Ratio data for Shandong Buchang Pharmaceuticals Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 2.09% | CN¥403.75 Million ≈ $59.08 Million |
CN¥19.33 Billion ≈ $2.83 Billion |
+0.39pp |
| 2023-12-31 | 1.69% | CN¥354.09 Million ≈ $51.81 Million |
CN¥20.89 Billion ≈ $3.06 Billion |
-1.61pp |
| 2022-12-31 | 3.31% | CN¥726.45 Million ≈ $106.30 Million |
CN¥21.95 Billion ≈ $3.21 Billion |
+1.23pp |
| 2021-12-31 | 2.08% | CN¥498.17 Million ≈ $72.90 Million |
CN¥23.99 Billion ≈ $3.51 Billion |
+0.39pp |
| 2020-12-31 | 1.69% | CN¥386.45 Million ≈ $56.55 Million |
CN¥22.89 Billion ≈ $3.35 Billion |
-0.14pp |
| 2019-12-31 | 1.82% | CN¥386.45 Million ≈ $56.55 Million |
CN¥21.19 Billion ≈ $3.10 Billion |
+1.76pp |
| 2017-12-31 | 0.07% | CN¥13.00 Million ≈ $1.90 Million |
CN¥19.20 Billion ≈ $2.81 Billion |
-0.47pp |
| 2016-12-31 | 0.54% | CN¥100.00 Million ≈ $14.63 Million |
CN¥18.67 Billion ≈ $2.73 Billion |
-- |
About Shandong Buchang Pharmaceuticals Co Ltd
Shandong Buchang Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of medicines in China. It offers medicines to treat cardiac and cerebral vascular, urinary and digestive, respiratory, gynecological, and other diseases, as well as diabetes. The company was founded in 1993 and is based in Heze, China.